Roth Capital Partners Initiates Coverage on Natera, Inc. with Buy Rating

Roth Capital Partners has initiated coverage on Natera, Inc. (NTRA) with a 'Buy' rating and set a price target of $475 per share. This move reflects positive analyst sentiment regarding Natera's market position and growth potential in the genetic testing sector.